Biosimilar Monoclonal Antibody Market contains market size and forecasts of Biosimilar Monoclonal Antibody in Global, including the following market information:
- Global Biosimilar Monoclonal Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biosimilar Monoclonal Antibody market was valued at 4706.7 million in 2021 and is projected to reach US$ 24410 million by 2028, at a CAGR of 26.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Limited Dilution Method Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biosimilar Monoclonal Antibody include Biocon, Accord Healthcare, AET Biotech, Amgen, Celltrion, Reddy's Laboratories, Hospira, 3SBio and Allergan and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biosimilar Monoclonal Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilar Monoclonal Antibody Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar Monoclonal Antibody Market Segment Percentages, by Type, 2021 (%)
- Limited Dilution Method
- Micromanipulation
- Soft Agar Plate Method
- Others
Global Biosimilar Monoclonal Antibody Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar Monoclonal Antibody Market Segment Percentages, by Application, 2021 (%)
- Chronic & Autoimmune Diseases
- Oncology
- Others
Global Biosimilar Monoclonal Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biosimilar Monoclonal Antibody Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biosimilar Monoclonal Antibody revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Biosimilar Monoclonal Antibody revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Biocon
- Accord Healthcare
- AET Biotech
- Amgen
- Celltrion
- Reddy's Laboratories
- Hospira
- 3SBio
- Allergan
- Alvartis
Industry Market Size
